The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
OncoKB: Automated annotation of the pathogenicity and treatment implications of germline mutations in cancer.
 
Moriah Nissan
No Relationships to Disclose
 
Nikita Mehta
No Relationships to Disclose
 
Hongxin Zhang
No Relationships to Disclose
 
Amanda Dhaneshwar
No Relationships to Disclose
 
Margaret Sheehan
No Relationships to Disclose
 
Yelena Kemel
No Relationships to Disclose
 
Calvin Lu
No Relationships to Disclose
 
Sarah Suehnholz
No Relationships to Disclose
 
Nicole Fernandez
No Relationships to Disclose
 
Hyeonjin Park
No Relationships to Disclose
 
Yirong Li
No Relationships to Disclose
 
Ciyu Yang
No Relationships to Disclose
 
Bree Martin
No Relationships to Disclose
 
Yonina Murciano-Goroff
Employment - Memorial Sloan Kettering Cancer Center (MSK has institutional financial interests relative to Elucida Oncology); Memorial Sloan-Kettering Cancer Center
Honoraria - Amgen; Virology Education
Consulting or Advisory Role - Abbvie; Revolution Medicines
Research Funding - Abbvie (Inst); Andrew Sabin Family Foundation; Bristol-Myers Squibb (Inst); Conquer Cancer, the ASCO Foundation; Conquer Cancer, the ASCO Foundation; Druckenmiller Center for Lung Cancer Research; Elucida Oncology (Inst); Endeavor BioMedicines (Inst); Hengrui Pharmaceutical (Inst); Jiangsu Hengrui Pharmaceuticals (Inst); Loxo Oncology / Eli Lilly (Inst); Loxo Oncology / Eli Lilly (Inst); Loxo/Lilly (Inst); Luzsana Biotechnology (Inst); Mirati Therapeutics (Inst); National Cancer Institute; National Cancer Institute; National Institutes of Health (NIH)/National Cancer Institute (NCI); Squeri Grant for Drug Development; Taiho Oncology (Inst); The Society of Memorial Sloan Kettering
Patents, Royalties, Other Intellectual Property - Rutgers University Press; Wolters Kluwer
Travel, Accommodations, Expenses - AstraZeneca; Loxo Oncology/ Eli Lilly
Other Relationship - Endeavor Biomedicines
 
Lauren Banaszak
No Relationships to Disclose
 
David Solit
Stock and Other Ownership Interests - Corramedical, Inc; Elsie Biotechnologies; Fore Biotherapeutics; Function Oncology; Melinda Therapeutics; Pyramid Biosciences; Scorpion Therapeutics; Vividion Therapeutics
Consulting or Advisory Role - BridgeBio Pharma; Corramedical; Elsie Biotechnologies; Fog Therapeutics; Fore Biotherapeutics; Function Oncology; Meliora Therapeutics; PAIGE.AI (I); Pfizer; Pyramid Biosciences; Rain Therapeutics; Scorpion Therapeutics; Vividion Therapeutics
 
Nikolaus Schultz
Honoraria - OneOncology
 
Zsofia Stadler
Consulting or Advisory Role - Adverum (I); Genentech/Roche (I); Neurogene (I); Novartis (I); Optos (I); Outlook Therapeutics (I); Regeneron (I)
Patents, Royalties, Other Intellectual Property - Intellectual property rights (SOPHiA Genetics) (Inst)
Other Relationship - JCO Precision Oncology, Associate Editor; UpToDate, Section Editor
 
Diana Mandelker
No Relationships to Disclose
 
Debyani Chakravarty
No Relationships to Disclose